Portland, OR, Dec. 21, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global pulmonary drug delivery systems market generated $49.78 billion in 2020, and is expected to reach $91.12 billion by 2030, witnessing a CAGR of 6.08% from 2021 to 2030. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.
Rise in prevalence of pulmonary diseases, technological advancements, and supportive government policies and awareness programs by private organizations drive the growth of the global pulmonary drug delivery systems market. However, high cost of pulmonary drug delivery systems hinders the market growth. On the other hand, surge in R&D activities in pulmonary drug delivery systems creates new opportunities in the coming years.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/2944
Impact of Covid-19 on Pulmonary Drug Delivery Systems Market-
- The Covid-19 outbreak made a positive impact on the pulmonary drug delivery systems market as patients suffering from asthma and COPD are at high risk of mortality if infected with Covid-19 and not treated on time. The demand for pulmonary drug delivery systems increased during the pandemic.
- The Covid-19 pandemic put huge stress on the healthcare systems across the globe and raised the need for the development of diagnostic instruments & treatment centers.
Get detailed COVID-19 impact analysis on the Pulmonary Drug Delivery Systems Market- https://www.alliedmarketresearch.com/request-for-customization/2944?reqfor=covid
The report offers detailed segmentation of the global pulmonary drug delivery systems market based on product, application, distribution channel, and region.
Based on product, the metered-dose inhaler segment accounted for the largest share in 2020, contributing to more than two-fifths of the total share, and is expected to maintain its lead position during the forecast period. However, the dry powder inhaler segment is estimated to manifest the largest CAGR of 6.6% from 2021 to 2030.
Based on distribution channel, the retail pharmacies segment held the highest share in 2020, contributing to more than half of the total share of the global pulmonary drug delivery systems market, and is estimated to maintain its dominant share during the forecast period. However, the e-commerce segment is estimated to witness the fastest CAGR of 7.6% from 2021 to 2030.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/2944
Based on region, North America contributed to the highest share in 2020, accounting for nearly half of the total market share, and is estimated to maintain its leadership status in terms of revenue by 2030. However, Asia-Pacific is estimated to portray the highest CAGR of 7.0% during the forecast period.
Leading players of the global pulmonary drug delivery systems market analyzed in the research include AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Koninklijke Philips N.V., Novartis AG, Actelion Pharmaceuticals Ltd (Janssen), 3M Company, Briggs Healthcare, Clement, Clarke International, and Aerogen.
Official Press Release- https://www.alliedmarketresearch.com/press-release/pulmonary-drug-delivery-systems-market.html
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer a cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
